Vectors Research Management’s Smith & Wesson SWBI Stock Holding History

Vectors Research Management’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50	Closed	-$1K	–	557
2021 Q4	$1K	Hold	50	–	–	﹤0.01%	581
2021 Q3	$1K	Sell	50 -350	-88%	-$8.41K	﹤0.01%	467
2021 Q2	$14K	Buy	+400	New	+$8.37K	﹤0.01%	348

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Vectors Research Management's SWBI Position: Q1 2022 in Review

Vectors Research Management sold out of Smith & Wesson (SWBI) in Q1 2022, closing a stake of 50 shares — an estimated $1K sold.

Vectors Research Management first reported a position in SWBI in Q2 2021 and held it in 3 quarters. The position peaked at $14K in Q2 2021. 223 funds tracked by Wall St. Rank hold SWBI as of Q1 2022.

Vectors Research Management reported no remaining Smith & Wesson position as of Q1 2022 after selling out during the quarter.
Vectors Research Management sold 50 Smith & Wesson shares in Q1 2022, an estimated $1K.
Vectors Research Management first reported a position in Smith & Wesson in Q2 2021 and held it in 3 quarters.
Vectors Research Management's Smith & Wesson position peaked at $14K in Q2 2021.
223 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2022.

Based on Vectors Research Management's 13F filing for Q1 2022, filed 16 May 2022.